Results 31 to 40 of about 662,438 (383)
Thrombocytopenia in end-stage renal disease and chronic viral hepatitis B or C [PDF]
, 2018 Objectives. We evaluated platelet counts in end-stage renal disease and chronic viral hepatitis. Materials and Methods. We studied 70 patients with end-stage renal disease and chronic viral hepatitis and compared them to a control group of 45 patients ...
Breaban, Iulia +12 more
core +4 more sources
Journal of Nepal Medical Association, 2021 Introduction: End-stage renal disease patients are in rising trend globally, and they have been found to occur predominantly in developing countries. Many studies have been published before, within and across the countries, to know the clinicodemographic
Madhav Ghimire +2 more
doaj +1 more source
Frailty in end stage renal disease: Current perspectives
Nefrología, 2022 Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD.
Shankar Prasad Nagaraju +2 more
doaj +2 more sources
Baclofen-Induced Encephalopathy in End Stage Renal Disease
Case Reports in Medicine, 2015 Baclofen is a highly used centrally acting GABA agonist that continues to be an effective therapy for spasticity and chronic hiccups. The renally dependent excretion determines the circulating concentrations and guides effective dosing to decrease ...
Andrew Meillier +2 more
doaj +1 more source
Evaluating epoetin dosing strategies using observational longitudinal data [PDF]
Annals of Applied Statistics 2014, Vol. 8, No. 4, 2356-2377, 2015 Epoetin is commonly used to treat anemia in chronic kidney disease and End Stage Renal Disease subjects undergoing dialysis, however, there is considerable uncertainty about what level of hemoglobin or hematocrit should be targeted in these subjects. In order to address this question, we treat epoetin dosing guidelines as a type of dynamic treatment ...
arxiv +1 more source
Targeting Immunity in End-Stage Renal Disease [PDF]
, 2017 Background: Despite the stable incidence of end-stage renal disease (ESRD), it continues to be associated with an unacceptably high cardiovascular risk.
Baragetti, Ivano +2 more
core +1 more source
Predicting Dosage of Immunosuppressant Drugs After Kidney Transplantation Using Machine Learning [PDF]
arXiv, 2023 While kidney transplants are seen as the best treatment option for patients with end-stage renal disease and kidney failure, the organ's health depends on the dosage of immunosuppressant drugs post-transplantation. Due to the dosage variance based on each patient's unique physiology, nephrologists face numerous difficulties when determining the precise
arxiv
Changing trends in end-stage renal disease patients with diabetes
Swiss Medical Weekly, 2017 BACKGROUND Worldwide, diabetes has become the most common cause of end-stage renal disease (ESRD), yet Swiss data are largely lacking. METHODS This observational study examined ESRD patients with ...
Yimin Lu +13 more
doaj +1 more source
Stereopsis in end-stage renal disease (ESRD) [PDF]
, 2017 We investigated an effect of end-stage renal disease (ESRD) on the visual system by measuring the ability of 21 patients to perceive depth in the random dot stereograms and circles of the Randot Test.
Butler, Laurie T. +3 more
core +1 more source
An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula [PDF]
, 2016 Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts. The disease is congenital and children that do not succumb to it during the neonatal period will, by age 10 years, more often than not, require nephrectomy+renal replacement therapy for ...
arxiv +1 more source